$INO Due to the urgency of finding a prevention, the team is skipping phase two and will enter phase three of testing in July, Bussen said.

Following successful trials in phase three, the vaccine could be cleared for FDA approval, Bussen added.

$MRNA $NVAX $VRTX $CODX $JNJ $MRK